Example: Heart Attack

Search clinical trials for: Anti-Dyskinesia Agents

Total 1299 results

NCT00686699

Terminated

Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)

Conditions: Akathisia, Drug-Induced; Dyskinesia, Drug-Induced; Parkinsonian Disorders
NCT02812147

Active, not recruiting

Effect of L-Dihydoxyphenylserine on Locomotion, Postural Stability, and Fall Risk Reduction in Parkinson Disease

Conditions: Parkinson Disease
NCT04510922

Recruiting

Lundbeck TOMs Orthostatic Hypotension

Conditions: Orthostatic Hypotension; Idiopathic Parkinson Disease
NCT03446807

Not yet recruiting

Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism

Conditions: Parkinson Disease; Multiple System Atrophy; Progressive Supranuclear Palsy
NCT03602014

Recruiting

Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury

Conditions: Hypotension, Orthostatic; Hypotension; Spinal Cord Injuries
NCT03567447

Recruiting

Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)

Conditions: Parkinson Disease; Falls Patient
NCT02624310

Withdrawn

A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis

Conditions: HSAN Type IV
NCT03229174

Recruiting

Brain Perfusion & Oxygenation in Parkinson's Disease With NOH

Conditions: Parkinson Disease; Neurogenic Orthostatic Hypotension
NCT03173781

Completed

Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease

Conditions: Parkinson's Disease
NCT03034564

Unknown status

A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's Disease

Conditions: Parkinson Disease; Fatigue; Parkinsonism
NCT02852213

Recruiting

A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

Conditions: AADC Deficiency
NCT02586623

Recruiting

Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension

Conditions: Symptomatic Neurogenic Orthostatic Hypotension
NCT02066571

Unknown status

Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease

Conditions: Parkinson's Disease; Freezing of Gait; Cognitive Ability, General
NCT01612078

Terminated

Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis Patients

Conditions: Orthostatic Hypotension
NCT02558972

Recruiting

Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)

Conditions: Postural Tachycardia Syndrome (POTS); Vasovagal Syncope (VVS); Fainting
NCT00738062

Completed

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Conditions: Neurogenic Orthostatic Hypotension; Non-Diabetic Autonomic Neuropathy; Multiple System Atrophy; Dopamine Beta Hydroxylase Deficiency
NCT02071459

Completed

Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA

Conditions: Multiple System Atrophy
NCT01468259

Withdrawn

A Multi-Center, Open-Label Study

Conditions: Renal Disease; End Stage Renal Disease
NCT01354158

Completed

A Dose Titration of Droxidopa in Patients With Spinal Cord Injury

Conditions: Spinal Cord Injury; Hypotension
NCT01331122

Withdrawn

Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease

Conditions: Gait Disorders, Neurologic
NCT01132326

Completed

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)

Conditions: Primary Autonomic Failure; Dopamine Beta Hydroxylase Deficiency; Non-Diabetic Neuropathy; Neurogenic Orthostatic Hypotension
NCT01149629

Completed

Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa

Conditions: Symptomatic Neurogenic Orthostatic Hypotension
NCT00977171

Terminated

Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome

Conditions: Chronic Fatigue Syndrome; Orthostatic Hypotension; Neurally Mediated Hypotension; Neurogenic Orthostatic Hypotension
NCT00889135

Approved for marketing

Long Term Treatment With L-DOPS

Conditions: Dopamine Beta Hydroxylase (DBH) Deficiency
NCT00782340

Completed

A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa

Conditions: Symptomatic Neurogenic Orthostatic Hypotension (NOH); Non-diabetic Neuropathy; Primary Autonomic Failure; Dopamine Beta Hydroxylase Deficiency